Fluoxetine Versus Fluoxetine Plus DU125530 in Latency of Antidepressant Response Shortening in Major Depressive Disorder.
Phase of Trial: Phase II
Latest Information Update: 10 May 2010
At a glance
- Drugs DU 125530 (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- 10 May 2010 New trial record